Significance of bone morphogenetic protein-4 function in the initial myofibrillogenesis of chick cardiogenesis

Dev Biol. 2002 May 15;245(2):291-303. doi: 10.1006/dbio.2002.0637.

Abstract

The heart is the first organ to form and function during vertebrate embryogenesis. Using a secreted protein, noggin, which specifically antagonizes bone morphogenetic protein (BMP)-2 and -4, we examined the role played by BMP during the initial myofibrillogenesis in chick cultured precardiac mesoendoderm (mesoderm + endoderm; ME). Conditioned medium from COS7 cells transfected with Xenopus noggin cDNA inhibited the expression of sarcomeric proteins (such as sarcomeric alpha-actinin, Z-line titin, and sarcomeric myosin), and so myofibrillogenesis was perturbed in cultured stage 4 precardiac ME; however, it did not inhibit the expression of smooth muscle alpha-actin (the first isoform of alpha-actin expressed during cardiogenesis). In cultured stage 5 precardiac ME, noggin did not inhibit either the formation of I-Z-I components or the expression of sarcomeric myosin, but it did inhibit the formation of A-bands. Although BMP4 was required to induce expressions of sarcomeric alpha-actinin, titin, and sarcomeric myosin in cultured stage 6 posterolateral mesoderm (noncardiogenic mesoderm), smooth muscle alpha-actin was expressed without the addition of BMP4. Interestingly, in cultured stage 6 posterolateral mesoderm, BMP2 induced the expressions of sarcomeric alpha-actinin and titin, but not of sarcomeric myosin. These results suggest that (1) BMP4 function lies upstream of the initial formation of I-Z-I components and A-bands separately in a stage-dependent manner, and (2) at least two signaling pathways are involved in the initial cardiac myofibrillogenesis: one is an unknown pathway responsible for the expression of smooth muscle alpha-actin; the other is BMP signaling, which is involved in the expression of sarcomeric alpha-actinin, titin, and sarcomeric myosin.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Biomarkers / analysis
  • Bone Morphogenetic Protein 4
  • Bone Morphogenetic Proteins / immunology
  • Bone Morphogenetic Proteins / metabolism*
  • COS Cells
  • Carrier Proteins
  • Cell Differentiation / drug effects
  • Cells, Cultured
  • Chick Embryo
  • Culture Media, Conditioned / pharmacology
  • Gastrula / cytology
  • Gastrula / drug effects
  • Gastrula / metabolism
  • Heart / drug effects
  • Heart / embryology*
  • In Situ Hybridization
  • Microscopy, Fluorescence
  • Muscle Development* / drug effects
  • Myocardium / cytology
  • Myocardium / metabolism*
  • Proteins / genetics
  • Proteins / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction / drug effects
  • Time Factors
  • Transfection
  • Xenopus
  • Xenopus Proteins

Substances

  • Biomarkers
  • Bone Morphogenetic Protein 4
  • Bone Morphogenetic Proteins
  • Carrier Proteins
  • Culture Media, Conditioned
  • Proteins
  • RNA, Messenger
  • Xenopus Proteins
  • bmp4 protein, Xenopus
  • noggin protein